2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner SyndromeCongenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Nutritional and Metabolic Diseases, Werner syndrome, hereditary disease, metabolic diseaseRecruitingPhase 22026-10-05NCT05847179
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Genomic Instability, Microsatellite Instability, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Werner syndrome, hereditary disease, metabolic diseaseRecruitingPhase 1 / Phase 22026-05-06NCT06898450